WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Breast Cancer Endpoints - Master, Concepts (e.g. CRF:pCR:Histology) are denoted by solid round-edged rectangle, Cancer type has_option DCIS, Overall response rate has_component Observed Response, Secondary endpoints has_component Quality-of-life (QoL) scores, Cancer type has_option IBC, Therapeutic Efficacy Point has Observation or Assessment, Cancer type has_option LCIS, Cancer type has_option Invasive, Secondary endpoints has_component Overall response rate, Therapeutic Efficacy Point has Therapeutic/Surgical intervention, FDA Criteria for Efficacy endpoint for Breast Cancer treatment has_pertinent_information Tumor information, Survival has_component Progression free survival (PFS), Cancer stage has_component M, Hormone receptor status has_component PR status, Secondary efficacy endpoints (e.g. Overall response rate) are denoted by italics font, Tumor assessment is_derived_from RECIST v1.0 criteria, Cancer stage has_component T, Quality-of-life (QoL) scores is_documented_by ECOG PS, Clinical benefit rate (CBR) has_component Observed Response, Overall Survival (OS) starts_concurrent_with Date of Randomization